Lv62
1800 积分 2024-03-29 加入
Global landscape of PROTAC: Perspectives from patents, drug pipelines, clinical trials, and licensing transactions
1小时前
已完结
Cyclin E in normal physiology and disease states
20天前
已完结
Using fungible biosensors to evolve improved alkaloid biosyntheses
21天前
已完结
Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor
22天前
已完结
Osteoarthritis
26天前
已完结
A cereblon-based glue degrader of NEK7 regulates NLRP3 inflammasome in a context-dependent manner
1个月前
已完结
Preclinical prediction of human pharmacokinetics
1个月前
已完结
Mining the CRBN target space redefines rules for molecular glue–induced neosubstrate recognition
1个月前
已完结
Inhibitors and PROTACs of CDK2: challenges and opportunities
1个月前
已完结
Targeting CDK2 to combat drug resistance in cancer therapy
1个月前
已完结
皖公网安备34019202002308
